Cellebrite DI (NASDAQ:CLBT – Get Free Report) and Yext (NYSE:YEXT – Get Free Report) are both technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.
Valuation & Earnings
This table compares Cellebrite DI and Yext”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cellebrite DI | $475.67 million | 5.83 | $78.33 million | $0.24 | 46.35 |
| Yext | $446.58 million | 1.71 | $37.87 million | $0.17 | 45.37 |
Cellebrite DI has higher revenue and earnings than Yext. Yext is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
45.9% of Cellebrite DI shares are owned by institutional investors. Comparatively, 71.0% of Yext shares are owned by institutional investors. 5.7% of Cellebrite DI shares are owned by company insiders. Comparatively, 7.8% of Yext shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Analyst Ratings
This is a summary of current ratings and recommmendations for Cellebrite DI and Yext, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cellebrite DI | 1 | 0 | 4 | 0 | 2.60 |
| Yext | 0 | 5 | 0 | 0 | 2.00 |
Cellebrite DI presently has a consensus price target of $14.75, suggesting a potential upside of 32.58%. Yext has a consensus price target of $6.33, suggesting a potential downside of 17.89%. Given Cellebrite DI’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Cellebrite DI is more favorable than Yext.
Volatility & Risk
Cellebrite DI has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500. Comparatively, Yext has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500.
Profitability
This table compares Cellebrite DI and Yext’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cellebrite DI | 12.14% | 17.47% | 9.28% |
| Yext | 5.90% | 43.23% | 7.50% |
Summary
Cellebrite DI beats Yext on 9 of the 14 factors compared between the two stocks.
About Cellebrite DI
Cellebrite DI Ltd. develops digital intelligence software and services that help organizations access, collect, preserve and analyze digital evidence. Its tools are used to investigate information from mobile devices, computers, cloud sources and other digital systems. The company’s offerings include its UFED platform for extracting data from digital devices, Physical Analyzer for examining and interpreting evidence, and analytics and case-management tools such as Pathfinder and Guardian. Customers include law enforcement, public safety, intelligence and defense agencies, as well as organizations in the private sector.
About Yext
Yext, Inc. provides software that helps businesses manage their digital presence and the information customers find about them online. Its platform enables organizations to maintain consistent business details, such as locations, hours and services, across websites, search engines, maps, directories and other digital services. Yext’s offerings include tools for managing online listings, business websites and pages, customer reviews, social media content and site search. The company also provides analytics to help organizations understand how people engage with their digital information.
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.
